Core Viewpoint - The Gross Law Firm is notifying shareholders of Telix Pharmaceuticals Ltd. regarding a class action lawsuit due to alleged misleading statements made by the company during a specified class period [1][3]. Group 1: Class Action Details - The class period for the lawsuit is from February 21, 2025, to August 28, 2025 [3]. - Allegations include that Telix Pharmaceuticals materially overstated its progress with prostate cancer therapeutic candidates and the quality of its supply chain and partners [3]. - As a result of these alleged misstatements, the company's statements about its business, operations, and prospects were deemed materially false and misleading [3]. Group 2: Shareholder Actions - Shareholders are encouraged to register for the class action by the deadline of January 9, 2026, to potentially be appointed as lead plaintiff [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [4]. - Participation in the case incurs no cost or obligation for the shareholders [4]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm focused on protecting investors' rights against deceit and fraud [5]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [5].
Shareholders of Telix Pharmaceuticals Ltd. Should Contact The Gross Law Firm Before January 9, 2026 to Discuss Your Rights – TLX